UroGen Pharma (LTS:0XOD) Machinery, Furniture, Equipment : $3.20 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is UroGen Pharma Machinery, Furniture, Equipment?

UroGen Pharma's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was $3.20 Mil.

UroGen Pharma's quarterly Machinery, Furniture, Equipment increased from Sep. 2024 ($3.07 Mil) to Dec. 2024 ($3.15 Mil) and increased from Dec. 2024 ($3.15 Mil) to Mar. 2025 ($3.20 Mil).

UroGen Pharma's annual Machinery, Furniture, Equipment increased from Dec. 2022 ($2.77 Mil) to Dec. 2023 ($2.91 Mil) and increased from Dec. 2023 ($2.91 Mil) to Dec. 2024 ($3.15 Mil).

UroGen Pharma Machinery, Furniture, Equipment Historical Data

The historical data trend for UroGen Pharma's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UroGen Pharma Machinery, Furniture, Equipment Chart

UroGen Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

2.27

2.66

2.77

2.91

3.15

UroGen Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															2.91	2.99	3.07	3.15	3.20

UroGen Pharma Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

UroGen Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UroGen Pharma Ltd (LTS:0XOD) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

URGN:USA UR8:Germany

Address

400 Alexander Park Drive, 4th Floor, Princeton, NJ, USA, 08540

Website

https://www.urogen.com

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

UroGen Pharma Headlines

No Headlines